Legacy Capital Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$521K Sell
1,482
-64
-4% -$22.8K 0.11% 199
2025
Q4
$506K Sell
1,546
-71
-4% -$22.5K 0.11% 200
2025
Q3
$456K Sell
1,617
-19
-1% -$5.51K 0.1% 220
2025
Q2
$457K Sell
1,636
-1,160
-41% -$329K 0.1% 216
2025
Q1
$871K Sell
2,796
-246
-8% -$72.6K 0.21% 97
2024
Q4
$793K Sell
3,042
-533
-15% -$158K 0.2% 101
2024
Q3
$1.15M Sell
3,575
-25
-0.7% -$8.18K 0.23% 91
2024
Q2
$1.12M Sell
3,600
-6,978
-66% -$2.05M 0.29% 66
2024
Q1
$2.58M Buy
10,578
+7,499
+244% +$2.19M 1.83% 17
2023
Q4
$887K Sell
3,079
-34
-1% -$9.26K 0.25% 90
2023
Q3
$837K Buy
+3,113
New +$777K 0.23% 90
2023
Q2
Sell
-2,829
Closed -$684K 50
2023
Q1
$684K Buy
+2,829
New +$694K 0.19% 108

Other funds holding AMGN

Legacy Capital Wealth Partners's AMGN Position: Q1 2026 in Review

Legacy Capital Wealth Partners reduced its Amgen (AMGN) stake by 4.1% in Q1 2026, selling an estimated $22.8K and leaving 1,482 shares worth $521K. The position accounts for 0.11% of the portfolio, ranked #199.

Legacy Capital Wealth Partners first reported a position in AMGN in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.58M in Q1 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Legacy Capital Wealth Partners held 1,482 shares of Amgen worth $521K as of Q1 2026.
  • Legacy Capital Wealth Partners sold 64 Amgen shares in Q1 2026, an estimated $22.8K.
  • Amgen made up 0.11% of Legacy Capital Wealth Partners's portfolio in Q1 2026, its #199 holding.
  • Legacy Capital Wealth Partners first reported a position in Amgen in Q1 2023 and has held it in 12 quarters since.
  • Legacy Capital Wealth Partners's Amgen position peaked at $2.58M in Q1 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.